Anticorps Monoclonal anti-RASGRP3

RASGRP3 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, souris

Applications

WB, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1A10G4

N° de cat : 66650-1-PBS

Synonymes

GRP3, KIAA0846, Ras guanyl releasing protein 3, RAS-GRP, RASGRP3



Informations sur le produit

66650-1-PBS cible RASGRP3 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène RASGRP3 Protéine recombinante Ag3810
Nom complet RAS guanyl releasing protein 3 (calcium and DAG-regulated)
Masse moléculaire calculée 690 aa, 78 kDa
Poids moléculaire observé 78 kDa
Numéro d’acquisition GenBankBC027849
Symbole du gène RASGRP3
Identification du gène (NCBI) 25780
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

AS guanyl releasing protein 3 (RasGRP3) is a member of the RasGRP family and is able to promote guanine nucleotide exchange of Ha-Ras, R-Ras and Rap1 (PMID: 9582122). RasGRP3 is involved in a diverse range of important biological processes. RasGRP3 has emerged as an important mediator of signaling downstream from receptor coupled phosphoinositide turnover in B and T cells. Overexpression of RasGRP3 is commonly associated with many malignancies, such as pre-Bcell leukemia, Burkitt’s lymphoma and natural killer-like T-cell leukemia. Recently, it has been reported that upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy (PMID: 24418912).

{{ptg:RelatedPrimaryAntibodies}}